Using the Omnipod 5 insulin pump for children with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how well the Omnipod 5, a smart insulin pump that automatically adjusts insulin, works for children and teens with type 1 diabetes. It aims to see if this pump helps manage blood sugar levels better in everyday life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 16 years old and have type 1 diabetes
- You are being cared for at the Pediatric Diabetes Center of HUDERF in Belgium
- You are starting to use the Omnipod 5 system between May 2025 and April 2026
- Your parents or guardians agree to the study, and you agree if you are old enough
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study compares two versions of the Omnipod insulin pump system to see if the newer Omnipod 6 works better at managing blood sugar than the current Omnipod 5. You'll wear one of these systems for several months and share data about how well it helps control your diabetes.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
This study tests whether starting automated insulin delivery (a system that adjusts insulin automatically) early after diagnosis helps children and teens with type 1 diabetes manage their blood sugar better. It also looks at long-term health and costs.
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.